On 22-24 September, the European Commission organised its first ever Research & Innovation Day in Brussels. The aim of this meeting was for the Commission to engage with stakeholders around the future Research and Innovation agenda for the period 2021-2027.
Europe is setting aside important funding for Horizon Europe and the five big Research Missions (cancer, cities, oceans, climate adaptation, and soil health and food). In terms of health care, different sessions focused on the issues around data collection, the translation from research output to societal impact, addressing the challenges posed by rare diseases, and the large issues around the prevention and awareness of prevalent diseases. ESE provided input to this Horizon Europe co-creation consultation, together with more than 6000 other stakeholders.
- ESE helped raise awareness for World Obesity Day on 11 October and World Osteoporosis Day on 20 October
- Prof Bulent Yildiz highlighted ESE’s ambition to reduce obesity by campaigning for additional research into the causes of this complex disorder
- ESE plans face-to-face meetings with Members of the European Parliament and other stakeholders in December. The delegation will be led by ESE President, Prof Andrea Giustina, and meetings will focus on rare diseases, endocrine disruptors, obesity, cancer research and many other key topics in endocrinology
- The development of the first endocrinology White Paper for Europe is becoming more concrete after a constructive workshop in Milan, attended by almost the entire ESE leadership. The launch of the White Paper is expected to take place in Brussels in March 2020 in or around the European Parliament.